Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
批准号:
10725231
负责人:
Hadiza S Kazaure
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2025-08-14
关键词:
AffectAgeAgingAlgorithmsAlzheimer&aposs DiseaseAmbulatory Care FacilitiesAmericanArtificial IntelligenceAwardBiochemicalBiochemical MarkersBiologicalCalciumCardiovascular systemCaringCharacteristicsChronicClinicClinic VisitsClinicalClinical assessmentsCognitionCognitive deficitsCreatinineDataDiagnosisDisease of parathyroid glandsDocumentationEarly DiagnosisEarly treatmentElderlyElectronic Health RecordEndocrineEndocrine Surgical ProceduresEndocrine System DiseasesEndocrinologyExclusionFractureGoalsGrowthHealthHealth systemHypercalcemiaHyperparathyroidismImpaired cognitionImpairmentKidneyKidney CalculiKnowledgeLearningMachine LearningMeasuresMemoryMemory impairmentMorbidity - disease rateNatural Language ProcessingNeurocognitionNeurocognitiveNeurocognitive DeficitNeuropsychological TestsOperative Surgical ProceduresOsteoporosisOutpatientsPTH geneParathyroid glandParathyroidectomyPatientsPatternPolypharmacyPopulationPrevalencePrizeProceduresProcessQuality of lifeRenal functionResearchResearch MethodologyResearch PersonnelSpecialistSurveysSymptomsTechniquesTestingTimeTwin Multiple BirthUnited StatesUnited States National Institutes of HealthUniversitiesVerbal LearningVisitVisuospatialVulnerable PopulationsWorkaging populationblindbone lossbrain fogcareer developmentcognitive functioncognitive testingcomorbiditydemographicsfollow-upfunctional declinehigh riskhuman old age (65+)improvedmachine learning methodneurocognitive testnon-verbalnovel strategiesolder patientpreservationprospectivepublic health relevanceresponsesymptomatic improvementtreatment guidelinestreatment response
中文摘要
项目总结
原发性甲状旁腺功能亢进症(PHPT)是一种常见的内分泌疾病,影响约100万老年人(年龄≥,65岁)
美国人。未经治疗的PHPT与骨质疏松症、骨折、肾结石、肾功能下降、
和心血管相关的发病率。然而,80%以上的PHPT患者缺乏典型症状
例如肾结石;它们通常是“无症状”的,即使骨丢失和肾功能衰退无声地发生。
神经认知(NC)症状,包括记忆障碍和认知功能障碍(“脑雾”),
常见的主观主诉,可能是患者出现的唯一症状。研究利用
目的神经认知测试发现PHPT患者的注意力明显降低
水平,非语言学习过程中的障碍,以及结构和视觉空间记忆的损害。
这些损伤导致老年人功能显著下降和生活质量(QOL)下降--
非常重视认知的保存作为一个关键的健康指标的人群。
甲状旁腺切除术通常作为门诊手术进行,是PHPT的一线治疗方法,通常
治愈了。一些研究表明,认知功能有所改善,甚至正常化
手术后的生活质量。尽管如此,PHPT作为一种诊断往往被忽视,高达70%的
老年人即使达到了手术治疗的标准,也没有得到充分的PHPT治疗。更进一步说,不
到目前为止,关于患有PHPT的老年人的NC症状的研究已经进行。因此,这里缺乏
老年人中与PHPT相关的NC症状的数据,包括可能是
在他们中普遍存在,以及他们对治疗的反应。
在这项建议中,我们的目标是(A)前瞻性地描述NC的症状和治疗-反应模式
使用经过验证的主观调查工具和一组3项客观NC测量对患有PHPT的老年人进行评估
和(B)制定一项以人工智能为基础的战略,将机器学习和自然语言结合起来
处理技术,以加快PHPT的诊断。所有研究将在杜克大学内进行
卫生系统。
这项建议的目的是:
1:老年人PHPT的NC症状特征
2:描述与PHPT相关的老年患者的治疗反应模式相关的因素
NC症状
3:开发一种基于人工智能的算法,以加快诊断患有PHPT的老年人
或无NC症状
英文摘要
PROJECT SUMMARY
Primary hyperparathyroidism (PHPT) is a common endocrine disorder affecting ~1 million older (age ≥ 65 years)
Americans. Untreated PHPT is associated with osteoporosis, fractures, kidney stones, renal function decline,
and cardiovascular-related morbidity. However, more than 80% of patients with PHPT lack classic symptoms
such as kidney stones; they are often “asymptomatic” even as bone loss and renal decline silently occur.
Neurocognitive (NC) symptoms, including memory impairment and cognitive dysfunction (“brain fog”), are
common subjective complaints and may be the only symptoms with which patients present. Studies utilizing
objective neurocognitive testing have found that PHPT patients have significantly diminished concentration
levels, impairments in nonverbal learning processes, and compromised constructional and visuospatial memory.
These impairments result in significant functional decline and decreased quality of life (QoL) in older adults – the
very subpopulation that prizes the preservation of cognition as a critical health metric.
Parathyroidectomy, commonly done as an outpatient procedure, is the first-line treatment for PHPT and is often
curative. Several studies have demonstrated improvements (and even normalization) in cognitive function and
quality of life following surgery. Nonetheless, PHPT is too often overlooked as a diagnosis, and up to 70% of
older adults are undertreated for PHPT even when they meet the criteria for surgical treatment. Further, no
studies on NC symptoms in older adults with PHPT have been conducted to date. Thus, there is a paucity of
data on PHPT-associated NC symptoms among older adults, including specific cognitive deficits that may be
prevalent among them and their response to treatment.
In this proposal, we aim to (a) prospectively characterize NC symptoms and treatment-response patterns for
older adults with PHPT using a validated subjective survey instrument and a battery of 3 objective NC measures
and (b) develop an artificial intelligence-based strategy incorporating machine learning and natural language
processing techniques, to expedite PHPT diagnosis. All studies will be conducted within the Duke University
Health System.
The aims of the proposal are:
1: Characterize NC symptoms of older adults with PHPT
2: Delineate factors associated with treatment-response patterns among older patients with PHPT-associated
NC symptoms
3: Develop an artificial intelligence-based algorithm to expedite the diagnosis of PHPT among older adults with
or without NC symptoms
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: